Riskpilot← Back to searchSign inGet full accessMEDIKA NOVA AS
ASActiveOrg 998382637Pilestredet 15, 0164 OsloOther education n.e.c. · NACE 8559Est. 20121 employees
Revenue 2025
NOK 3M
+10% vs 2024
EBITDA margin
-16.3%
-1271% vs 2024
Equity ratio
37.8%
Financial strength
Net profit 2025
NOK -484K
-314% vs 2024
| Revenue | NOK 3M | +10% |
| EBITDA | NOK -489K | -1271% |
| Net profit | NOK -484K | -314% |
| Total assets | NOK 1,7M | -47% |
| Equity | NOK 633K | -43% |
| Employees | 1 | — |
Legal name
MEDIKA NOVA AS
Org number
998382637
Legal form
Aksjeselskap
NACE code
8559 · Other education n.e.c.
Founded
15. mai 2012
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Undervisning innenfor fagområdet nevrorefleksologi, i tillegg skal selskapet investere i andre selskaper, kjøp og utleie av eiendom, og det som naturlig sammenfaller med dette.
Address
Pilestredet 15, 0164 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 546 | 1 939 | 3 932 | 2 734 | 2 994 |
| Staff expenses | −1 019 | −1 171 | −1 184 | −1 296 | −1 447 |
| EBITDA | −203 | −491 | 692 | 42 | −489 |
| Depreciation & amort. | −0 | −0 | −8 | −51 | −10 |
| EBIT | −203 | −491 | 684 | −9 | −499 |
| Net financials | 113 | −113 | 182 | 355 | 13 |
| Profit before tax | −90 | −604 | 866 | 345 | −486 |
| Tax | −0 | −0 | 70 | 120 | −2 |
| Net profit | −90 | −604 | 795 | 226 | −484 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 167 | 1 433 | 3 105 | 3 187 | 1 674 |
| Equity | 1 951 | 1 347 | 2 041 | 1 117 | 633 |
| Long-term debt | 0 | 0 | 632 | 649 | 0 |
| Short-term debt | 216 | 86 | 433 | 1 422 | 191 |
| Total debt | 216 | 86 | 1 065 | 2 071 | 1 041 |
EBITDA margin
-16.3%
This company
15.8%
Market median
-203% vs market
20212025
Equity ratio
37.8%
This company
38.2%
Market median
+1% vs market
20212025
Return on equity
-76.4%
This company
18.4%
Market median
-515% vs market
20212025
Net profit margin
-16.2%
This company
8.1%
Market median
-300% vs market
20212025
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20212025
Debt / equity
1.65×
This company
0.62×
Market median
-166% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KN Chief Executive Officer | Chief Executive Officer | 2012 |
PI Deputy Member | Deputy Member | 2012 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDIKA NOVA AS 
REFLEKSOLOGGRUPPEN ASBoard members of MEDIKA NOVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kåre Nordanger | Chief Executive Officer | 0 companies |
| Per Ivar Hoff | Deputy Member | 0 companies |